Multicentre, randomised, double-blind, placebo-controlled phase II study of prophylactic olanzapine for patients with metastatic breast cancer receiving T-DXd treatment: protocol for the ERICA study (WJOG14320B).
Hitomi SakaiJunji TsurutaniYukinori OzakiHiroshi IshiguroKazuki NozawaKenichi WatanabeShigeto MaedaTakamichi YokoeChiyo K ImamuraKoji MatsumotoTsutomu IwasaYasutaka ChibaDaisuke TakiguchiToshimi TakanoPublished in: BMJ open (2023)
jRCTs031210410.